Clinical Partners

Prof Hashim Ahmed

Professor Hashim Ahmed is currently Chair of Urology at Imperial College London. Hashim is an internationally renowned expert in prostate cancer diagnosis, imaging and biopsy as well as minimally invasive therapies for prostate cancer such as HIFU and cryotherapy – either whole-gland or focal therapy for primary prostate cancer or radiorecurrent disease.

He has taught dozens of surgeons in these techniques in the UK and around the world and given numerous invited international lectures in this area. He has an extensive research portfolio with about £6M in grant income as a principal applicant and co-applicant to a research programme of approximately £14M.

He has published over 150 peer-reviewed papers in areas that have led to key changes in the way we diagnose and treat men with localised prostate cancer. He currently holds a £2.1M Wellcome Trust Senior Clinical Research Fellowship and is Director of the Wellcome Trust Prostate Research in Imaging and Surgical Methodology (PRISM) Programme.

Mr Richard Hindley

Having qualified in Scotland at the University of Dundee, Richard spent his initial surgical training in Brighton before embarking on 6 years specialist Urology training based in the South Thames training region. This included 2 years at King’s Hospital before passing his final surgical exams and travelling to Brisbane for a laparoscopic urology fellowship in 2003. He was later appointed as a consultant in Basingstoke in 2004. Since then he has spent the last 10 years developing the local service and his interests in minimally invasive treatments for urological conditions.

Richard is now the clinical lead in Urology in his department at the North Hampshire Hospital. He has introduced cutting edge treatments including the first centre outside of London offering day case laser prostate surgery for BPH in 2005. He is also a recognised expert in prostate cancer diagnosis and focal treatment using technologies such as HIFU and Cryotherapy. Basingstoke is now one of the leading centres in the UK and receives referrals from across the South of England. He has very much been at the forefront of treatments for benign and malignant conditions of the prostate.

Dr Clare Allen

Clare qualified from Oxford University and is Consultant Radiologist at UCL with an academic interest in uro-oncology, in particular prostate MR-imaging. She has a well-developed clinical practice in dynamic contrast-enhanced MR in the prostate and is leading a team of medical physicists in further defining the role of multi-sequence MRI in diagnostic utility of prostate cancer.

Mr Marc Laniado

Since 2002, Mr Laniado has been a consultant in London and Berkshire and is the Prostate Cancer lead at Wexham Park Hospital (Frimley Health). He designed the prostate cancer diagnostic pathway for the hospital. He consults patients in Windsor and Harley Street, and specialises in rapid diagnostic techniques and minimally invasive treatments for prostate enlargement and prostate cancer. He trained in the UK and the USA.

Mr Tim Dudderidge

Mr Dudderidge is one of the UK’s leaders in prostate cancer management. He is one of a handful of clinicians combining an interest in imaging and precision diagnostics with skills in both focal therapy and robotic assisted laparoscopic surgery.

Mr Dudderidge is one of two surgeons leading the prostate cancer service at University Hospital Southampton. In the past few years he has helped transform the service with innovations in the diagnostic pathway, development of new therapies including High Intensity Focused Ultrasound and focal Cryotherapy and recently led the efforts to deliver a robotic surgery service in the Spire Southampton Hospital.

During the same period Mr Dudderidge has also led the development of a prostate cancer research programme. The work has included evaluation of new urinary markers for cancer detection, investigation of HIFU and new imaging techniques in prostate cancer management. Mr Dudderidge was the principal investigator in Southampton for the PROMIS study. Southampton was the 3rd biggest contributor to the landmark multicentre study which confirmed the value of MP-MRI in prostate cancer assessment.

Peter Thompson Urological SurgeonThumb
Professor Peter Thomson

Peter Thompson is Consultant Urological Surgeon to the department of Urology at Kings College Hospital, London and Hunterian Professor at the Royal College of Surgeon of England

Prof Mark Emberton

Mark is Dean of UCL Faculty of Medical Sciences and Honorary Consultant Urologist at UCL. Leading an internationally recognised research group which looks at better diagnosis and treatment for men with prostate cancer, he is a major grant holder, a frequent speaker at international meetings and has published over 250 peer-reviewed scientific papers. He is chief investigator on a number of MRI-based diagnostic and interventional studies and has been elected as a Fellow of the Academy of Medical Sciences.

Alan Doherty

Alan is Consultant Urologist at Queen Elizabeth Hospital Birmingham, and was voted one of the UK’s top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail.

Mr Doherty is the founder of the Birmingham Prostate Clinic, an innovative centre allowing patients to track their individual recovery and compare outcomes in a clear and meaningful way.

Simon Bott

Simon is currently a Consultant Urologist at Frimley Park Hospital in Surrey. His surgical interests include minimally invasive treatment of prostate cancer and he continues to research ways of improving prostate cancer diagnosis, including fusion guided targeted biopsies. He has performed over 100 template biopsy procedures in the past year and is also involved with the early trials in prostate cancer focal therapy.

Mark Lynch

Mr Mark Lynch is a full time Consultant Urological Surgeon at Croydon University Hospital (CUH) and St George’s Hospital, London. He is currently Clinical Lead for Urology and Chair of the Cancer MDT at CUH and Consultant in the Endourology Unit at St George’s Hospital London.